Sachs Associates would like to say we enjoyed hosting you at our 8th Annual Neuroscience Innovation Forum (#Sachs_NIF). We would like to thank those who joined us in-person in San Francisco and those who participated virtually. A special thank you goes to the excellent lineup of sponsors, chairs, panellists and presenters who made such a broad and interesting programme possible.
The NIF has proven to be successful in supporting our community with over 450 people from 22 countries registered and a busy meeting system.
We look forward to welcoming you again to our future events!
SILVER SPONSOR:
BRONZE SPONSOR:
CONTRIBUTING SPONSOR:
Presenting Companies Included:
Cumulus Neuroscience
Noema Pharma AG
Confirmed Keynote Speakers Included:
Andrew Stelzer
Head of Business Development, Unlearn.AI, Inc.
David Feifel
Founding President, Kadima Neuropsychiatry Institute
Jonathan Javitt
CEO, NRx Pharmaceuticals, Inc.
Speakers and Chairs Included:
Bruce Leuchter
President & CEO, Neurvati Neurosciences, Inc.
Daniel Lee
Partner, PJT Partners
Ginger Johnson
SVP, Neuroscience Lead, Lumanity
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Jeffrey Cohen
Director of Research, Ladenburg Thalmann & Co. Inc.
Joel Sandler
Associate Partner, Ipsos Healthcare Advisory Service
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie, Inc.
Sumant Kulkarni
Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC
Thomas Shrader
Managing Director & Healthcare Analyst, BTIG, LLC
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
Carla Lema Tomé
Executive Director Business Development, Head of US BD, Otsuka Pharmaceutical Co., Ltd.
Christopher Reyes
CEO, Bloom Science, Inc.
Daniel Karlin
Chief Medical Officer, MindMed
Doug Drysdale
CEO, Cybin Inc.
Eliseo Salinas
Head of R&D, Delix Therapeutics, Inc.
Erwin Böttinger
CEO, Wyss Center for Bio and Neuroengineering
Fabio De Luca
Executive VP Corporate Development, Angelini Pharma S.p.A.
Gaia Skibinski
Director of Discovery & Translational Research, The Michael J. Fox Foundation for Parkinson's Research
Greg Mayes
President & CEO, Reunion Neuroscience, Inc.
Gregor Macdonald
VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S
Ilise Lombardo
CEO, Noema Pharma AG
James Cavuoto
Editor & Publisher, Neurotech Reports
Jens Wendland
Chief Medical Officer, Kynexis Therapeutics
Jon Walsh
Founder & VP of Technology, Unlearn.AI, Inc.
Joseph Tucker
CEO, Enveric BioSciences, Inc.
Julie Rachline
CEO, BrainTale
Kabir Nath
CEO, Compass Pathways
Ken Mariash
CEO, Sinaptica Therapeutics, Inc.
Kuldeep Neote
Entrepreneur In Residence, National Institute on Aging (NIA)
Laszlo Kiss
CBO & Head of Research, Gilgamesh Pharmaceuticals
Lisa Ricciardi
President & CEO, Cognition Therapeutics, Inc.
Mankit Law
Senior Director, BD, Search & Evaluation, GSK
Paolo Di Giorgio
Managing Director & CEO, Angelini Ventures S.p.A.
Peter Schlecht
Venture Partner, GOLDTRACK Ventures GmbH
Sahil Kirpekar
Managing Partner, Lumina Life Sciences
Sander van Deventer
CEO, VectorY Tx
Seth Lederman
Chairman & CEO, Tonix Pharmaceuticals Holding Corp.
Shaheen Lakhan
Chief Medical Officer, Click Therapeutics, Inc.
Vikram Sudarsan
President & CEO, Engrail Therapeutics, Inc.